Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial (pages 825–835)
YOSHINOSUKE FUKUCHI, LENORA FERNANDEZ, HAN-PIN KUO, AZIAH MAHAYIDDIN, BARTOLOME CELLI, MARC DECRAMER, STEVEN KESTEN, DACHENG LIU and DONALD TASHKIN
Article first published online: 28 JUN 2011 | DOI: 10.1111/j.1440-1843.2011.01982.x
Subgroup analysis of Asian subjects with COPD enrolled in the international multi-centre UPLIFT trial demonstrates that this population benefits from treatment with inhaled tiotropium. For subjects receiving tiotropium, improvements were observed in lung function, exacerbation frequency, health-related quality of life and mortality.
Vol. 16, Issue 8, 1281, Article first published online: 27 OCT 2011